Key points from article :
Nanoparticulate RNA immunotherapy puts pieces of cancer’s genetic RNA into tiny nanoparticles of fat and injects into the bloodstream.
Patient’s immune systems respond by producing T-cells designed to attack cancer.
Successful safety trial in three patients in the advanced stage of disease – also saw positive results.
Vaccine also effective in fighting aggressively growing tumours in mice.
Such vaccines are fast and inexpensive to produce and could target virtually any type of cancer.
The study was published in the Nature journal.
